Dr. Alice Gottlieb discusses the latest advancements in biologic and small molecule therapies for hidradenitis suppurativa (HS), highlighting emerging treatments that are transforming patient care.
Topics Covered:
- Innovations in biologic therapies for HS
- Emerging small molecule treatments
- Clinical implications of new HS therapies
Explore Related Resources:
Jennifer Hsiao, MD: Recalcitrant Hidradenitis Suppurativa—What to Do Next
Finasteride in Hidradenitis Suppurativa: A “Male” Therapy for a Predominantly Female Disease